- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06803719
Public Perceptions Toward Robotic Surgery, Telesurgery and Telemedicine
December 31, 2025 updated by: Ling Zhan, Shanghai 6th People's Hospital
Public Awareness, Trust, and Risk Perception Toward Robotic Surgery, Telesurgery and Telemedicine
This study aims to systematically assess the public's and clinicians' levels of awareness, attitudes, risk perception, acceptance, and potential concerns regarding robotic surgery and telesurgery.
It also analyzes the key factors influencing their attitudes and explores the needs of physicians regarding training systems for robotic and telesurgery, as well as the factors affecting their preparedness.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Public level:
- Level of awareness and understanding of robotic and remote surgery (e.g., understanding of operating procedures, the doctor's role, and potential risks).
- Perceptions and concerns regarding the safety, reliability, cybersecurity risks, and equipment malfunctions of the technology.
- Trust and acceptance of the technology, and factors that may influence attitudes (e.g., education level, past medical experiences, access to medical resources).
- Overall expectations and concerns regarding hospitals performing such surgeries.
Healthcare practitioners level:
- Knowledge level, attitudes, and acceptance of robotic and remote surgery.
- Views on the learning curve, surgical safety, equipment accessibility, collaborative processes, and potential obstacles.
- Understanding and actual needs regarding training systems for robotic and remote surgery, including simulator training, mentorship programs, skill evaluation methods, and the transfer of laparoscopic skills to robotic skills.
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ling Zhan, Dr
- Phone Number: 08615821120972
- Email: 15821120972@163.com
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200233
- Recruiting
- Shanghai sixth people's hospital
-
Contact:
- Ling Zhan, Doctor
- Phone Number: 08615821120972
- Email: rebecca0428zhan@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The general public sample included residents of mainland China aged 18 and older who were able to understand and complete the questionnaire, regardless of gender, region, or occupation.
The aim was to assess the general public's awareness, risk perception, trust, and acceptance of robotic surgery and remote surgery.
The clinical physician sample included practicing physicians from surgical specialties (such as general surgery, urology, gynecology, thoracic surgery, thyroid surgery, etc.), including residents, attending physicians, and chief/deputy chief physicians of different seniority levels.
Description
Inclusion Criteria:
- Chinese citizens aged 18 years or older
- Able to understand and complete the questionnaire
- Voluntarily participating in this study and providing informed consent
Exclusion Criteria:
- Aged below 18 years
- Unable to understand the questionnaire or unable to complete the questionnaire independently
- Those who submit the questionnaire repeatedly
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Public group
The general public sample included residents of mainland China aged 18 and older who were able to understand and complete the questionnaire, regardless of gender, region, or occupation.
The aim was to assess the general public's awareness, risk perception, trust, and acceptance of robotic surgery and remote surgery.
|
Anonymous online questionnaire assessing public and physician perceptions of robotic surgery, telesurgery and telemedicine
|
|
Physician group
The clinical physician sample included practicing physicians from surgical specialties (such as general surgery, urology, gynecology, thoracic surgery, thyroid surgery, etc.), including residents, attending physicians, and chief/deputy chief physicians of different seniority levels.
This group of physicians was used to assess healthcare professionals' awareness, experience, perceived risks, expectations for future applications of robotic and remote surgery, as well as their views on training needs, feasibility, and barriers to training.
|
Anonymous online questionnaire assessing public and physician perceptions of robotic surgery, telesurgery and telemedicine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Public acceptance of robotic surgery
Time Frame: Baseline
|
The level of acceptance toward robotic surgery among the general public, measured using a 5-point Likert scale assessing willingness to receive robotic-assisted procedures under hypothetical clinical scenarios.
Higher scores indicate greater acceptance.
|
Baseline
|
|
Public acceptance of telesurgery and telemedicine
Time Frame: Baseline
|
The degree of acceptance of telesurgery among the general public, assessed via a validated questionnaire evaluating willingness to undergo remote surgery, perceived safety, and perceived reliability of network-based surgical systems.
|
Baseline
|
|
Public perceived risk of robotic and telesurgery
Time Frame: Baseline
|
Perceived risk associated with robotic surgery and telesurgery, including concerns about device malfunction, network failure, surgical autonomy, and responsibility attribution, assessed using a multi-item Likert scale.
Higher scores indicate higher perceived risk.
|
Baseline
|
|
Physicians' training needs score (assessed by self-designed questionnaire)
Time Frame: Baseline
|
This measure assesses physicians' perceived training needs regarding required skills (e.g., simulation, console operation) and preferred modalities (e.g., online courses, wet labs).
Participants rate items on a 5-point Likert scale (1=Not needed, 5=Highly needed).
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ling Zhan, Dr, Shanghai 6th People's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
January 27, 2025
First Submitted That Met QC Criteria
January 27, 2025
First Posted (Actual)
January 31, 2025
Study Record Updates
Last Update Posted (Estimated)
January 2, 2026
Last Update Submitted That Met QC Criteria
December 31, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-KY-507(K)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Data are available on request due to privacy or other restrictions.
The data that support the findings of this study are available on request from Ling Zhan.
The data are not publicly available due to them containing information that could compromise research participant privacy.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Telemedicine
-
Michigan State UniversityUniversity of Michigan; Wake Forest University Health Sciences; Babes-Bolyai...CompletedUsual Care | Telemedicine: Smoking Cessation App Only | Telemedicine: Smoking Cessation Counseling | Telemedicine: App + CounselingRomania
-
Attune Health Research, Inc.Rheumatology Research FoundationRecruiting
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyCompleted
-
Wake Forest University Health SciencesCompleted
-
National University Health System, SingaporeCompletedTelemedicineSingapore
-
CochlearCompletedTelemedicineUnited States
-
The Hong Kong Polytechnic UniversityCompleted
-
Wake Forest University Health SciencesCompleted
-
Buzzi Children's HospitalCompleted
Clinical Trials on Survey Questionnaire
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Mbarara University of Science and...Completed
-
M.D. Anderson Cancer CenterCompleted
-
Frederiksberg University HospitalTerminated
-
First Affiliated Hospital of Wenzhou Medical UniversityQilu Hospital of Shandong University; Eastern Hepatobiliary Surgery Hospital; The First Affiliated Hospital of Zhejiang Chinese Medical UniversityEnrolling by invitationEfficacy | Liver Cancer | Adverse Event | Microbiota | PrognosisChina
-
Second Affiliated Hospital, School of Medicine,...Enrolling by invitation
-
Samsung Medical CenterActive, not recruitingOccupational Diseases | Emergency DepartmentsKorea, Republic of
-
Stanford UniversityCompletedBreast CancerUnited States
-
Peking University Third HospitalCompleted
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)UnknownGlioma | Brain TumorUnited States, Finland, Sweden, Denmark, Israel, United Kingdom